Clinical Trial

QUAD-HF - Prospective Registry of Patients With Incident Heart Failure and Left Ventricular Ejection Fraction <50%

Study acronym: QUAD-HF
Recruiting
View on ClinicalTrials.gov →
Summary
The QUAD-HF registry is an observational study that would enroll patients in the United Kingdom, who have been newly diagnosed with heart failure and a left ventricular ejection fraction \<50%. We plan to assess clinical outcomes in these patients, such as hospitalization and death, in relation to their diagnosis, implementation of guidelines and type of treatments these patients have received.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-12; most recent amendment 2025-12-08.
Status change: Not Yet Recruiting → Recruiting 2025-12-08
Trial Details
NCT Number NCT07174362
Lead Sponsor Mid and South Essex NHS Foundation Trust
Collaborators: Anglia Ruskin University, British Society for Heart Failure
Conditions Heart Failure
Enrollment 4,000 participants
Start Date 2025-10-06
Primary Completion 2030-11 (estimated)
Study Completion 2031-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-16